1. Home
  2. CRI vs NNNN Comparison

CRI vs NNNN Comparison

Compare CRI & NNNN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Carter's Inc.

CRI

Carter's Inc.

HOLD

Current Price

$33.21

Market Cap

1.3B

ML Signal

HOLD

Logo Anbio Biotechnology Class A Ordinary Shares

NNNN

Anbio Biotechnology Class A Ordinary Shares

HOLD

Current Price

$26.00

Market Cap

1.5B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRI
NNNN
Founded
1865
2021
Country
United States
Germany
Employees
N/A
N/A
Industry
Apparel
Biotechnology: In Vitro & In Vivo Diagnostic Substances
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2002
N/A

Fundamental Metrics

Financial Performance
Metric
CRI
NNNN
Price
$33.21
$26.00
Analyst Decision
Hold
Analyst Count
5
0
Target Price
$34.00
N/A
AVG Volume (30 Days)
1.0M
66.2K
Earning Date
06-01-2026
01-01-0001
Dividend Yield
2.38%
N/A
EPS Growth
N/A
N/A
EPS
0.75
N/A
Revenue
$2,844,102,000.00
N/A
Revenue This Year
$2.49
N/A
Revenue Next Year
$0.21
N/A
P/E Ratio
$56.24
$446.57
Revenue Growth
N/A
N/A
52 Week Low
$23.38
$5.91
52 Week High
$44.44
$55.65

Technical Indicators

Market Signals
Indicator
CRI
NNNN
Relative Strength Index (RSI) 35.74 49.37
Support Level $28.71 $20.19
Resistance Level $33.53 $31.92
Average True Range (ATR) 1.92 2.94
MACD -0.44 0.45
Stochastic Oscillator 5.63 52.24

Price Performance

Historical Comparison
CRI
NNNN

About CRI Carter's Inc.

Carter's Inc makes apparel for babies and children under brand names including Carter's and OshKosh B'gosh. It sells its products through a multi-channel business model, which includes retail stores, eCommerce, and wholesale sales channels, as well as retail omnichannel capabilities in the United States and Canada, which enables it to reach a broad range of consumers around the world. The company operates in three segments; U.S. Retail, U.S. Wholesale, and International. The majority of revenue is derived from U.S. Wholesale segment. The company predominantly sources products through contract manufacturers in Asia. It has multiple distribution centers in the U.S., in addition to distribution centers in Canada and Asia that serve international customers.

About NNNN Anbio Biotechnology Class A Ordinary Shares

Anbio Biotechnology is a medical device company focused on in vitro diagnostics. It offers laboratory, wellness, at-home, and point-of-care (POCT) in vitro diagnostic (IVD) solutions to detect a wide range of biomarkers associated with critical medical domains encompassing infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Its product portfolio comprises AF-1200 Fluorescence Immunoassay Analyzer, SHA-100 Dry Chemistry Analyzer, Ferritin Rapid Test Kit, Dengue NS1 Rapid Test, Multi-HBV Rapid Test, COVID-19 Test Kit (Real-time PCR), and others. Geographically, the company generates maximum revenue from the European Union, followed by South America, Asia Pacific, North America, and other regions.

Share on Social Networks: